Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
KAZIA THERAPEUTICS TO PRESENT AT BIO CEO CONFERENCE 2022-02-07 21:00
Samsung Biologics receives 2022 CMO Leadership Award in all six categories 2022-02-07 20:00
Ascletis Announces Positive Data of Oral Double Prodrug ASC10 and Its Antiviral Nucleoside Analog ASC10-A Against Omicron Variant 2022-02-07 19:00
The one-component Sputnik Light vaccine has been authorized in India; over 2.5 billion people live in countries that approved Sputnik Light as a standalone vaccine and a universal booster 2022-02-07 08:18
Everest Medicines Announces First Drug Approval of Trodelvy® in Singapore for Second-Line Metastatic Triple-Negative Breast Cancer 2022-02-07 08:00
Ascletis Announces U.S. IND Approval of Oral PD-L1 Small Molecule Inhibitor ASC61 for Treatment of Advanced Solid Tumors 2022-02-06 18:30
Vitro S.A. sells Cytognos to BD to prioritize the market launch of their new and disruptive Molecular Biology and Anatomic Pathology diagnostic platforms 2022-02-04 17:23
Nanoform signs GMP manufacturing program with TargTex following formulation success 2022-02-04 15:54
New Zealand's Medsafe Grants Provisional Approval for Novavax' COVID-19 Vaccine 2022-02-04 06:54
Mentice publishes the company's year-end report for the period January-December 2021 2022-02-03 15:37
CordenPharma Completes Acquisition of Three Manufacturing Facilities from Vifor Pharma 2022-02-02 11:00
World's most trusted source for chemistry information, CAS, launches major biology expansion 2022-02-02 10:42
New Business Partnership Between Otsuka Pharmaceutical and Digital Health VR Technology Developer Jolly Good 2022-02-01 21:00
Cytiva fuels biotech development in Australia and New Zealand 2022-02-01 07:00
DEBIOPHARM AND ASPEN PARTNER TO LAUNCH PROSTATE CANCER DRUG TRELSTAR® IN SOUTH AFRICA 2022-02-01 06:00
Denovo Biopharma LLC Announces FDA Approval of IND to Initiate First Biomarker-Guided Global CNS Clinical Trial for Treatment-Resistant Depression (TRD) 2022-02-01 05:30
Novavax Submits Request to the U.S. FDA for Emergency Use Authorization of COVID-19 Vaccine 2022-02-01 04:06
Exopharm and Astellas Institute for Regenerative Medicine (AIRM) Sign Master Collaborative Services Agreement 2022-01-31 19:00
HanBio Therapeutics Announces the Completion of a US$40 Million Series A Financing Led by OrbiMed and Hankang Capital 2022-01-29 11:37
Aurealis Therapeutics and Xbiome Enter into a License and Collaboration Agreement for Aurealis Four-in-One Diabetic Foot Ulcer and Inflammatory Disease Cell and Gene Therapy AUP-16 in Greater China 2022-01-29 05:28
1 200 201 202 203 204 420